Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interferon associated retinopathy.

Literature DB >> 9602634

Interferon associated retinopathy.

S Hayasaka¹, Y Nagaki, M Matsumoto, S Sato.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1998 PMID： 9602634 PMCID： PMC1722505 DOI： 10.1136/bjo.82.3.323

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

19 in total

1. Virus interference. I. The interferon.

Authors: A ISAACS; J LINDENMANN
Journal: Proc R Soc Lond B Biol Sci Date: 1957-09-12

2. Regression of experimental iris neovascularization with systemic alpha-interferon.

Authors: J W Miller; W G Stinson; J Folkman
Journal: Ophthalmology Date: 1993-01 Impact factor: 12.079

3. Local interferon alfa-2b for ocular cicatricial pemphigoid.

Authors: M Gillies; I Francis; P McCluskey; D Wakefield
Journal: Br J Ophthalmol Date: 1996-10 Impact factor: 4.638

4. Clinical characteristics of hepatitis C virus-associated retinopathy.

Authors: T Abe; A Nakajima; N Satoh; T Koizumi; S Sakuragi; T Ono; M Komatsu; O Masamune
Journal: Jpn J Ophthalmol Date: 1995 Impact factor: 2.447

5. Recombinant leukocyte A interferon in Kaposi's sarcoma.

Authors: S E Krown; F X Real; M Krim; S Cunningham-Rundles; B Koziner; P L Myskowski; B Safai; H F Oettgen
Journal: Ann N Y Acad Sci Date: 1984 Impact factor: 5.691

6. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis.

Authors: R Sundmacher; K Cantell; R Skoda; C Hallermann; D Neumann-Haefelin
Journal: Albrecht Von Graefes Arch Klin Exp Ophthalmol Date: 1978-11-30

7. [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].

Authors: S Soushi; F Kobayashi; H Obazawa; K Kigasawa; K Shiraishi; M Itakura; S Matsuzaki
Journal: Nippon Ganka Gakkai Zasshi Date: 1996-01

8. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.

Authors: S Hayasaka; M Fujii; Y Yamamoto; S Noda; H Kurome; M Sasaki
Journal: Br J Ophthalmol Date: 1995-02 Impact factor: 4.638

9. Interferon-associated retinopathy.

Authors: D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal: Arch Ophthalmol Date: 1993-03

10. [Interferon-induced retinal changes].

Authors: T Chuman; N Nao-i; A Sawada; T Kawano; M Shigehira
Journal: Nippon Ganka Gakkai Zasshi Date: 1994-06

25 in total

1. Severe interferon associated retinopathy.

Authors: K L Tu; J Bowyer; K Schofield; S Harding
Journal: Br J Ophthalmol Date: 2003-02 Impact factor: 4.638

2. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.

Authors: Kaori Mochizuki; Tatehiro Kagawa; Shinji Takashimizu; Kazuya Kawazoe; Sei-Ichiro Kojima; Naruhiko Nagata; Atsushi Nakano; Yasuhiro Nishizaki; Koichi Shiraishi; Masaru Itakura; Norihito Watanabe; Tetsuya Mine; Shohei Matsuzaki
Journal: World J Gastroenterol Date: 2004-03-01 Impact factor: 5.742

3. Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.

Authors: J Garcia-Arumi; M Morral Palau; M Montolio Gil; H Blasco Garrido; L Sararols Ramsay; A Segura García
Journal: Br J Ophthalmol Date: 2006-04 Impact factor: 4.638

Interferon associated retinopathy.

1. Virus interference. I. The interferon.

2. Regression of experimental iris neovascularization with systemic alpha-interferon.

3. Local interferon alfa-2b for ocular cicatricial pemphigoid.

4. Clinical characteristics of hepatitis C virus-associated retinopathy.

5. Recombinant leukocyte A interferon in Kaposi's sarcoma.

6. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis.

7. [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].

8. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.

9. Interferon-associated retinopathy.

10. [Interferon-induced retinal changes].

1. Severe interferon associated retinopathy.

2. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.

3. Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.

4. Pegylated interferon alpha-associated optic neuropathy.

Review 5. The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

6. Association of Ledipasvir-Sofosbuvir Treatment With Uveitis in Patients Treated for Hepatitis C.

Review 7. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.

8. [Combined retinal artery and vein occlusions associated with interferon beta therapy].

9. Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C.

10. Depression following pegylated interferon-alpha: characteristics and vulnerability.